Abstract
Introduction: The incidence of depression in adolescents is increasing and is associated with severe cognitive impairment. This paper aimed to investigate the relationship between polymorphisms in microRNA-146a-5p (miR-146a-5p) and cognitive impairment in adolescent depression patients. Methods: Quantitative real-time polymerase chain reaction was used to quantify miR-146a-5p in serum. Detection of miR-146a-5p gene polymorphism was performed by TaqMan SNP Genotyping Assay. Odds ratios and 95% confidence intervals (CIs) were calculated by chi-square test (χ2) and logistic regression analysis. Results: Genotyping of miR-146a rs2910164 showed that CC (OR = 0.443, 95% CI, 0.264–0.741, p = 0.002) and GC (OR = 0.445, 95% CI, 0.279–0.712, p = 0.001) genotype reduced the risk of cognitive impairment in adolescent depression. The C allele (OR = 0.794, 95% CI, 0.694–0.741, p = 0.001) was a protective factor for cognitive impairment in adolescent depression compared to the rs2910164 G allele. Rs2910164 (OR = 0.425, 95% CI = 0.273–0.662, p = 0.000) showed a negative correlation with adolescents with cognitive impairment in depression by logistic regression analysis. The level of miR-146a-5p was decreased in carriers of the CC and CG genotypes. Conclusion: Rs2910164 C allele carriers have a low risk of cognitive impairment in adolescent depression and could reduce miR-146a-5p level.
Journal Section:
Original Article
References
1.
Howard
DM
, Adams
MJ
, Clarke
TK
, Hafferty
JD
, Gibson
J
, Shirali
M
, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions
. Nat Neurosci
. 2019
;22
(3
):343
–52
. 2.
Li
J
, Zhou
X
, Huang
Z
, Shao
T
. Effect of exercise intervention on depression in children and adolescents: a systematic review and network meta-analysis
. BMC Public Health
. 2023
;23
(1
):1918
. 3.
Spittaels
K
, Van den Haute
C
, Van Dorpe
J
, Terwel
D
, Vandezande
K
, Lasrado
R
, et al. Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice
. Neuroscience
. 2002
;113
(4
):797
–808
. 4.
Li
L
, Ma
L
. Guidelines for the prevention and treatment of depressive disorders in China. Chinese psychiatric
. Journal
. 2017
;50
(003
):21
.5.
Wagner
S
, Doering
B
, Helmreich
I
, Lieb
K
, Tadić
A
. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment
. Acta Psychiatr Scand
. 2012
;125
(4
):281
–92
. 6.
Lee
RS
, Hermens
DF
, Porter
MA
, Redoblado-Hodge
MA
. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder
. J Affect Disord
. 2012
;140
(2
):113
–24
. 7.
Brush
CJ
, Hajcak
G
, Bocchine
AJ
, Ude
AA
, Muniz
KM
, Foti
D
, et al. A randomized trial of aerobic exercise for major depression: examining neural indicators of reward and cognitive control as predictors and treatment targets
. Psychol Med
. 2022
;52
(5
):893
–903
. 8.
Atique-Ur-Rehman
H
, Neill
JC
. Cognitive dysfunction in major depression: from assessment to novel therapies
. Pharmacol Ther
. 2019
;202
:53
–71
. 9.
Dotson
VM
, McClintock
SM
, Verhaeghen
P
, Kim
JU
, Draheim
AA
, Syzmkowicz
SM
, et al. Depression and cognitive control across the lifespan: a systematic review and meta-analysis
. Neuropsychol Rev
. 2020
;30
(4
):461
–76
. 10.
Lopez
JP
, Fiori
LM
, Cruceanu
C
, Lin
R
, Labonte
B
, Cates
HM
, et al. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
. Nat Commun
. 2017
;8
:15497
. 11.
Fan
C
, Li
Y
, Lan
T
, Wang
W
, Long
Y
, Yu
SY
. Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression
. Mol Ther
. 2022
;30
(3
):1300
–14
. 12.
Prada
I
, Gabrielli
M
, Turola
E
, Iorio
A
, D’Arrigo
G
, Parolisi
R
, et al. Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations
. Acta Neuropathol
. 2018
;135
(4
):529
–50
. 13.
Lucanic
M
, Plummer
WT
, Chen
E
, Harke
J
, Foulger
AC
, Onken
B
, et al. Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects
. Nat Commun
. 2017
;8
:14256
. 14.
Cui
DM
, Zeng
T
, Ren
J
, Wang
K
, Jin
Y
, Zhou
L
, et al. KLF4 knockdown attenuates TBI-induced neuronal damage through p53 and JAK-STAT3 signaling
. CNS Neurosci Ther
. 2017
;23
(2
):106
–18
. 15.
Fuchs
C
, Trazzi
S
, Torricella
R
, Viggiano
R
, De Franceschi
M
, Amendola
E
, et al. Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling
. Neurobiol Dis
. 2014
;70
(100
):53
–68
. 16.
Nguyen
HD
, Kim
MS
. The protective effects of curcumin on depression: genes, transcription factors, and microRNAs involved
. J Affect Disord
. 2022
;319
:526
–37
. 17.
Caldeira
C
, Cunha
C
, Vaz
AR
, Falcão
AS
, Barateiro
A
, Seixas
E
, et al. Key aging-associated alterations in primary microglia response to beta-amyloid stimulation
. Front Aging Neurosci
. 2017
;9
:277
. 18.
Sierksma
A
, Lu
A
, Salta
E
, Vanden Eynden
E
, Callaerts-Vegh
Z
, D’Hooge
R
, et al. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
. Mol Neurodegener
. 2018
;13
(1
):54
. 19.
Zhan-Qiang
H
, Hai-Hua
Q
, Chi
Z
, Miao
W
, Cui
Z
, Zi-Yin
L
, et al. miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling
. Neurologia
. 2023
;38
(7
):486
–94
. 20.
Zhang
J
, Gao
L
, Yang
GL
, Kong
Z
. The effect of single nucleotide polymorphisms on depression in combination with coronary diseases: a systematic review and meta-analysis
. Front Endocrinol
. 2024
;15
:1369676
. 21.
Zhang
X
, Huo
Q
, Sun
W
, Zhang
C
, Wu
Z
, Xing
B
, et al. Rs2910164 in microRNA-146a confers an elevated risk of depression in patients with coronary artery disease by modulating the expression of NOS1
. Mol Med Rep
. 2018
;18
(1
):603
–9
. 22.
Zhang
B
, Wang
A
, Xia
C
, Lin
Q
, Chen
C
. A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer’s disease and is associated with the pathogenesis of Alzheimer’s disease
. Mol Med Rep
. 2015
;12
(3
):4037
–42
. 23.
Jazdzewski
K
, Murray
EL
, Franssila
K
, Jarzab
B
, Schoenberg
DR
, de la Chapelle
A
. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
. Proc Natl Acad Sci U S A
. 2008
;105
(20
):7269
–74
. 24.
Simiand
J
, Keane
PE
, Morre
M
. The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents
. Psychopharmacol Berl
. 1984
;84
(1
):48
–53
. 25.
Jiang
W
, Xu
J
, Lu
XJ
, Sun
Y
. Association between MTHFR C677T polymorphism and depression: a meta-analysis in the Chinese population
. Psychol Health Med
. 2016
;21
(6
):675
–85
. 26.
Czamara
D
, Muller-Myhsok
B
, Lucae
S
. The P2RX7 polymorphism rs2230912 is associated with depression: a meta-analysis
. Prog Neuro-Psychopharmacol Biol Psychiatry
. 2018
;82
:272
–7
. 27.
Rimay
T
, Benak
I
, Kiss
E
, Baji
I
, Feher
A
, Juhasz
A
, et al. BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression
. Psychiatr Genet
. 2015
;25
(6
):249
–55
. 28.
Zhuo
C
, Tian
H
, Chen
J
, Li
Q
, Yang
L
, Zhang
Q
, et al. Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes
. Front Genet
. 2022
;13
:880027
. 29.
Pu
M
, Wang
X
, Zhang
J
. Impact of GRIK4 gene polymorphisms on cognitive dysfunction in patients with major depression
. Rev Neurol Paris
. 2020
;176
(10
):823
–8
. 30.
Sun
N
, Yang
C
, He
X
, Liu
Z
, Liu
S
, Li
X
, et al. Impact of expression and genetic variation of microRNA-34b/c on cognitive dysfunction in patients with major depressive disorder
. Neuropsychiatr Dis Treat
. 2020
;16
:1543
–54
. 31.
Deng
Y
, Gong
P
, Han
S
, Zhang
J
, Zhang
S
, Zhang
B
, et al. Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorder
. Psychol Med
. 2023
;53
(13
):6253
–60
. 32.
Anderson
BJ
. Plasticity of gray matter volume: the cellular and synaptic plasticity that underlies volumetric change
. Dev Psychobiol
. 2011
;53
(5
):456
–65
. 33.
Kubota
K
, Nakano
M
, Kobayashi
E
, Mizue
Y
, Chikenji
T
, Otani
M
, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells
. PLoS One
. 2018
;13
(9
):e0204252
. 34.
Dong
H
, Li
J
, Huang
L
, Chen
X
, Li
D
, Wang
T
, et al. Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer’s disease
. Dis Markers
. 2015
;2015
:625659
. 35.
Hu
Y
, Zhang
Q
, Wang
JC
, Wang
J
, Liu
Y
, Zhu
LY
, et al. Resveratrol improves diabetes-induced cognitive dysfunction in part through the miR-146a-5p/TXNIP axis
. Kaohsiung J Med Sci
. 2023
;39
(4
):404
–15
. 36.
Cui
L
, Li
Y
, Ma
G
, Wang
Y
, Cai
Y
, Liu
S
, et al. A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients
. PLoS One
. 2014
;9
(2
):e89019
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
